These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27063278)

  • 1. Nonalcoholic Fatty Liver Disease.
    Gaglio PJ
    Clin Liver Dis; 2016 May; 20(2):xiii-xiv. PubMed ID: 27063278
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonalcoholic fatty future disease.
    Polyzos SA; Mantzoros CS
    Metabolism; 2016 Aug; 65(8):1007-16. PubMed ID: 26805015
    [No Abstract]   [Full Text] [Related]  

  • 3. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    ; LaBrecque DR; Abbas Z; Anania F; Ferenci P; Khan AG; Goh KL; Hamid SS; Isakov V; Lizarzabal M; Peñaranda MM; Ramos JF; Sarin S; Stimac D; Thomson AB; Umar M; Krabshuis J; LeMair A;
    J Clin Gastroenterol; 2014 Jul; 48(6):467-73. PubMed ID: 24921212
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease in Latinos.
    Saab S; Manne V; Nieto J; Schwimmer JB; Chalasani NP
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):5-12; quiz e9-10. PubMed ID: 25976180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight loss outcomes after liver biopsy in patients with nonalcoholic fatty liver disease.
    You DM; Volk CG; Philo L; Partridge BJ
    Dig Liver Dis; 2014 Dec; 46(12):1136-7. PubMed ID: 25241133
    [No Abstract]   [Full Text] [Related]  

  • 6. Which patients with nonalcoholic fatty liver disease should undergo liver biopsy?
    Lindenmeyer CC; McCullough AJ
    Cleve Clin J Med; 2017 Apr; 84(4):273-275. PubMed ID: 28388384
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liver diseases. Non-alcoholic fatty liver disease].
    Bernal Reyes R
    Rev Gastroenterol Mex; 2010 Aug; 75 Suppl 1():181-3. PubMed ID: 20959244
    [No Abstract]   [Full Text] [Related]  

  • 8. Foreword. Nonalcoholic Fatty Liver Disease.
    Day CP; Anstee QM
    Semin Liver Dis; 2015 Aug; 35(3):203-6. PubMed ID: 26378638
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver histology and clinical trials for nonalcoholic steatohepatitis-perspectives from 2 pathologists.
    Kleiner DE; Bedossa P
    Gastroenterology; 2015 Nov; 149(6):1305-8. PubMed ID: 26409177
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Disease and Liver Transplantation.
    Pham T; Dick TB; Charlton MR
    Clin Liver Dis; 2016 May; 20(2):403-17. PubMed ID: 27063277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease.
    Sanyal AJ; Mathurin P; Nagy LA
    Gastroenterology; 2016 Jun; 150(8):1695-7. PubMed ID: 27155520
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonalcoholic Fatty Liver Disease: An Expanding Health Care Epidemic.
    Bernstein DE
    Clin Liver Dis; 2018 Feb; 22(1):xiii-xiv. PubMed ID: 29128064
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current Status and Future Prospects of Nonalcoholic Fatty Liver Disease (NAFLD) in Japan-Feedback from Clinical and Basic Researches to Medical Therapy and Pharmacist Activities].
    Tokuyama S; Kim KI
    Yakugaku Zasshi; 2016; 136(4):563. PubMed ID: 27040339
    [No Abstract]   [Full Text] [Related]  

  • 14. [Non-alcoholic fatty liver diseases].
    Roeb E; Steffen HM; Bojunga J
    Dtsch Med Wochenschr; 2015 Dec; 140(24):1846. PubMed ID: 26625237
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes.
    Ahmed A; Wong RJ; Harrison SA
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2062-70. PubMed ID: 26226097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nonalcoholic fatty liver disease: What do we know and what will we have to learn?].
    Volkova NI; Porksheyan MI
    Ter Arkh; 2017; 89(2):91-98. PubMed ID: 28393828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis.
    Kanwar P; Kowdley KV
    Clin Liver Dis; 2016 May; 20(2):225-43. PubMed ID: 27063266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic Fatty Liver Disease and Incident Cardiac Events: The Multi-Ethnic Study of Atherosclerosis.
    Zeb I; Li D; Budoff MJ; Katz R; Lloyd-Jones D; Agatston A; Blumenthal RS; Blaha MJ; Blankstein R; Carr J; Nasir K
    J Am Coll Cardiol; 2016 Apr; 67(16):1965-6. PubMed ID: 27102512
    [No Abstract]   [Full Text] [Related]  

  • 19. [Non alcoholic fatty liver: a growing epidemic].
    Montes Teves P
    Rev Gastroenterol Peru; 2016; 36(3):195-196. PubMed ID: 27716754
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
    Satapathy SK; Sanyal AJ
    Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.